LINDEN ADVISORS LP - MONTEREY BIO ACQUISITION COR ownership

MONTEREY BIO ACQUISITION COR's ticker is and the CUSIP is 61240F116. A total of 32 filers reported holding MONTEREY BIO ACQUISITION COR in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
LINDEN ADVISORS LP ownership history of MONTEREY BIO ACQUISITION COR
ValueSharesWeighting
Q3 2023$8,068
-14.7%
322,7000.0%0.00%
Q2 2023$9,455
+2.8%
322,7000.0%0.00%
Q1 2023$9,197
+8.4%
322,7000.0%0.00%
Q4 2022$8,487
-39.4%
322,7000.0%0.00%
Q3 2022$14,000
-46.2%
322,7000.0%0.00%
Q2 2022$26,000
-61.2%
322,7000.0%0.00%
Q1 2022$67,000
-46.0%
322,7000.0%0.00%
-100.0%
Q4 2021$124,000322,7000.00%
Other shareholders
MONTEREY BIO ACQUISITION COR shareholders Q3 2023
NameSharesValueWeighting ↓
MANGROVE PARTNERS IM, LLC 500,000$4,980,0000.27%
BOOTHBAY FUND MANAGEMENT, LLC 384,993$3,835,0000.09%
Radcliffe Capital Management, L.P. 200,000$1,993,0000.04%
EHP Funds Inc. 895,644$194,0000.03%
Murchinson Ltd. 500,000$108,0000.02%
ATW SPAC MANAGEMENT LLC 384,993$84,0000.01%
MMCAP International Inc. SPC 625,000$136,0000.01%
K2 PRINCIPAL FUND, L.P. 400,000$87,0000.01%
BASSO CAPITAL MANAGEMENT, L.P. 224,096$49,0000.01%
CVI Holdings, LLC 218,685$47,0000.00%
View complete list of MONTEREY BIO ACQUISITION COR shareholders